Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
Running, not enrolling · Phase 2
Conditions studied: Soft Tissue Sarcoma, Sarcoma,Soft Tissue
In brief
The proposed study is designed to treat locally advanced soft tissue sarcoma (STS) subtypes with neoadjuvant talimogene laherparepvec (TVEC) and preoperative external beam radiation therapy (EBRT).
Key facts
- Study ID
- NCT06660810
- Run by
- John Rieth
- People needed
- 2
- Starts
- 2025-03-03
- Expected to finish
- 2031-02-24
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Iowa — Iowa City, Iowa, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.